Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Tirzepatide doses of 10 mg and 15 mg resulted in lower body weight reductions of 12.8% and 14.7% respectively in individuals with overweight or obesity and T2DM [121]
Hair loss was a particularly notable finding, as it is not widely recognized as a potential effect
Conclusion Semaglutide is a long-acting GLP-1 medication commonly used for type 2 diabetes management and weight loss
It is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
